THE HBF PILL

Serial Number 97264241
Registration 7050850
700

Registration Progress

Application Filed
Feb 11, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered
May 9, 2023

Trademark Image

THE HBF PILL

Basic Information

Serial Number
97264241
Registration Number
7050850
Filing Date
February 11, 2022
Registration Date
May 9, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 9, 2023
Registration
Registered
Classes
005

Rights Holder

Fulcrum Therapeutics, Inc.

03
Address
26 Landsdowne Street
Cambridge, MA 02139

Ownership History

Fulcrum Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Fulcrum Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Joshua S. Jarvis

USPTO Deadlines

Next Deadline
1216 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20230509)
Due Date
May 09, 2029
Grace Period Ends
November 09, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Mar 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 5, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 5, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 2, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 2, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 2, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 2, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 9, 2023 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
May 9, 2023 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 4, 2023 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 30, 2023 ALIE A ASSIGNED TO LIE Loading...
Mar 17, 2023 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Mar 16, 2023 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Mar 16, 2023 IUAA P USE AMENDMENT ACCEPTED Loading...
Mar 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 13, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 13, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 14, 2023 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Mar 14, 2023 IUAF S USE AMENDMENT FILED Loading...
Mar 13, 2023 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Dec 13, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 13, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 13, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 27, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of hematological rare and genetically defined diseases and disorders
First Use Anywhere: Feb 15, 2023
First Use in Commerce: Feb 15, 2023

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PILL"